Evidence map›Paper›PMID 37615876›Full record

ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2023

Protein profiling of extracellular vesicles from iPSC-derived astrocytes of patients with ALS/PDC in Kii peninsula.

Hiroya Kobayashi, Koji Ueda, Satoru Morimoto, Mitsuru Ishikawa, Nicolas Leventoux, Ryogen Sasaki, Yoshifumi Hirokawa, Yasumasa Kokubo, Hideyuki Okano

Abstract read
PubMed Publisher
In one paragraph

Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Hiroya KobayashiDepartment of Physiology, Keio University School of Medicine, Tokyo, Japan.ORCID https://orcid.org/0009-0002-0995-0355
Koji UedaCancer Precision Medicine Center, Japanese Foundation of Cancer Research, Tokyo, Japan.ORCID https://orcid.org/0000-0001-9066-4959
Satoru MorimotoDepartment of Physiology, Keio University School of Medicine, Tokyo, Japan. satoru_morimoto@keio.jp.ORCID https://orcid.org/0000-0003-0022-9529
Mitsuru IshikawaDepartment of Physiology, Keio University School of Medicine, Tokyo, Japan.ORCID https://orcid.org/0009-0000-9895-7238
Nicolas LeventouxDepartment of Physiology, Keio University School of Medicine, Tokyo, Japan.ORCID https://orcid.org/0000-0001-7023-9859
Ryogen SasakiSchool of Nursing, Suzuka University of Medical Science, Mie, Japan.ORCID https://orcid.org/0000-0001-9716-6493
Yoshifumi HirokawaDepartment of Oncologic Pathology, Mie University Graduate School of Medicine, Mie, Japan.ORCID https://orcid.org/0000-0003-3219-7170
Yasumasa KokuboKii ALS/PDC Research Center, Mie University Graduate School of Regional Innovation Studies, Mie, Japan.ORCID https://orcid.org/0000-0003-2058-7673
Hideyuki OkanoDepartment of Physiology, Keio University School of Medicine, Tokyo, Japan. hidokano@keio.jp.ORCID http://orcid.org/0000-0001-7482-5935
Keio University · JPMie University · JPJapanese Foundation For Cancer Research · JPSuzuka University of Medical Science · JP

Funding

Japan Agency for Medical Research and Development 17ek0109139h0003Japan Agency for Medical Research and Development JP20ek0109329Japan Agency for Medical Research and Development JP20ek0109395Japan Agency for Medical Research and Development JP21wm0425009Japan Agency for Medical Research and Development JP22bm0804003Japan Agency for Medical Research and Development JP23bm1123046Japan Agency for Medical Research and Development JP23bm1423002Japan Agency for Medical Research and Development JP23kk0305024Japan Society for the Promotion of Science JP15J03921Japan Society for the Promotion of Science JP15K09364Japan Society for the Promotion of Science JP17H01689Japan Society for the Promotion of Science JP18K07368Japan Society for the Promotion of Science JP18K07514Japan Society for the Promotion of Science JP18KK0239Japan Society for the Promotion of Science JP19K08002Japan Society for the Promotion of Science JP19K17002Japan Society for the Promotion of Science JP20H00485Japan Society for the Promotion of Science JP21F21410Japan Society for the Promotion of Science JP21H05273Japan Society for the Promotion of Science JP21H05278Japan Society for the Promotion of Science JP22K15736Japan Society for the Promotion of Science JP22KF0333Japan Society for the Promotion of Science JP25305030Ministry of Health, Labour and Welfare 21210301Ministry of Health, Labour and Welfare H29-Nanchi- Ippan-085
6 · The paper itself

Abstract

backgroundAmyotrophic lateral sclerosis/Parkinsonism-dementia complex in Kii peninsula, Japan (Kii ALS/PDC), is an endemic neurodegenerative disease whose causes and pathogenesis remain unknown. However, astrocytes in autopsied cases of Kii ALS/PDC show characteristic lesions. In addition, relationships between extracellular vesicles (EVs) and neurodegenerative diseases are increasingly apparent. Therefore, we focused on proteins in EVs derived from Kii ALS/PDC astrocytes in the present study.

methodsInduced pluripotent stem cells (iPSCs) derived from three healthy controls (HCs) and three patients with Kii ALS/PDC were differentiated into astrocytes. EVs in the culture medium of astrocytes were collected and subjected to quantitative proteome analysis.

resultsOur proteome analysis reveals that EV-containing proteins derived from astrocytes of patients with Kii ALS/PDC show distinctive patterns compared with those of HCs. Moreover, EVs derived from Kii ALS/PDC astrocytes display increased proteins related to proteostasis and decreased proteins related to anti-inflammation. DISCUSSION: Proteins contained in EVs from astrocytes unveil protective support to neurons and may reflect the molecular pathomechanism of Kii ALS/PDC; accordingly, they may be potential biomarker candidates of Kii ALS/PDC.

Indexed as

Amyotrophic Lateral SclerosisExtracellular VesiclesInduced Pluripotent Stem CellsNeurodegenerative DiseasesAstrocytesHumansJapanProteomeProteomeALS/PDCAstrocyteExtracellular vesicleiPSCKii peninsulaProteome analysis

Identifiers

PMID37615876
OpenAlexW4386117269

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.